Halim Ozcevik

Dr. Halim Ozcevik

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2024 in Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Verified
Journal Article
Closed access
MTMerve Nur Acar Tayyar
Merve Nur Acar Tayyar
MTMuge Oner Tamam
Muge Oner Tamam
GBGündüzalp Buğrahan Babacan
Gündüzalp Buğrahan Babacan
MŞMehmet Can Şahin
Mehmet Can Şahin
HOHalim Ozcevik
Halim Ozcevik
KAKadir Atakır
Kadir Atakır

18 February 2025 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
PDF file
HOHalim Ozcevik
Halim Ozcevik
MTMuge Oner Tamam
Muge Oner Tamam
GBGündüzalp Buğrahan Babacan
Gündüzalp Buğrahan Babacan
SESelma Şengi̇z Erhan
Selma Şengi̇z Erhan
MTMerve Nur Acar Tayyar
Merve Nur Acar Tayyar
BEBi̇rAy Ertürk
Bi̇rAy Ertürk
Background/aim: This study aimed to investigate the relationship between the presence of BRAF, HRAS, NRAS, and KRAS gene mutations and the development of dedifferentiation (iodine-refractory disease) and extrathyroidal disease in patients with differentiated thyroid carcinoma (DTC).Materials and methods: Seventy-seven adult patients classified as intermediate and high-risk according to the ATA 2015 guidelines, who underwent total thyroidectomy followed by radioiodine I-131(RAI) therapy between June 2014 and December 2022, were included. Clinical data were collected via the hospital information system, including the number of surgeries, RAI treatments, and levels of thyroglobulin(Tg), anti-thyroglobulin, and thyroid-stimulating hormone. Histopathological subtypes of DTC were re-evaluated, and mutation analyses of BRAF, KRAS, NRAS, and HRAS genes were performed using real-time polymerase chain reaction (PCR). Statistical analyses were conducted using Medcalc software, with p-values <0.05 considered significant.Results: Of the 77 patients, most had classical papillary thyroid carcinoma, while others represented various subtypes. No mutations were found in BRAF K601E/V600_K601, KRAS G12x-G13D, or NRAS G12-G13; however, NRAS Q61x was found in one patient, HRAS Q61x in 12, and BRAFV600E/Ec in 36. A significant relationship was observed between HRAS Q61x mutation and disease response, alongside a significant association between gene mutations and iodine-refractory disease development (p=0.0004). ROC curve analysis indicated a 49.2 ng/ml threshold for Tg with 75% sensitivity and 94.1% specificity.Conclusion: Our findings suggest that the HRAS Q61x gene mutation is significantly associated with iodine-resistant disease and may serve as a prognostic biomarker in early-stage thyroid cancer and aid in disease monitoring in metastatic patients.

19 October 2022 in Molecular Imaging and Radionuclide Therapy
Verified
Journal Article
Open access
HOHalim Ozcevik
Halim Ozcevik
MTMuge Oner Tamam
Muge Oner Tamam
MTMehmet Tarık Tatoğlu
Mehmet Tarık Tatoğlu
MMMehmet Mülazımoğlu
Mehmet Mülazımoğlu
Objectives: The aim of this study was to compare Technetium-99m (Tc-99m)-sestamibi dual-phase planar imaging method and delayed phase single photon emission computed tomography/computed tomography (SPECT/CT) imaging in patients with primary hyperparathyroidism and to evaluate the accuracy of scintigraphy with histopathological results. Methods: Thirty-six patients with a prediagnosis of hyperparathyroidism, who had not been operated on the neck region before, and were not followed up for any other malignancy, and has confirmed histopathologic and biochemical diagnosis after parathyroidectomy, were retrospectively scanned and included in the study. The images of 36 patients who underwent dual-phase Tc-99m-sestamibi planar scintigraphy at the 20th and 120th minutes in the nuclear medicine clinic and delayed phase SPECT/CT imaging immediately after the 120th minute planar imaging were evaluated visually by two nuclear medicine specialists as positive or negative lesion. Dual-phase planar and SPECT/CT images were statistically compared in terms of sensitivity, specificity, positive predictive value, negative predictive value, and accuracy. Results: Thirty-six patients with 41 lesions were evaluated. Comparing dual-phase planar imaging and delayed phase SPECT/CT revealed, sensitivity 84.21%-94.74%, specificity 66.67%-66.67%. Positive predictive value 96.97%-97.30%, negative predictive value 25%-50.0%, accuracy 82.93%-92.68% respectively. There was a statistically significant difference between planar imaging and SPECT/CT; SPECT/CT localized the lesion more accurately (p<0.05). Conclusion: SPECT/CT is superior to planar imaging in determining the anatomical details and localization of the lesion, especially in determining the depth of the lesions in the neck and whether it is ectopic. In patients with hyperparathyroidism, SPECT/CT should be used routinely to detect parathyroid pathologies because it has a lower rate of error and higher accuracy rate.

5 February 2025 in Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Verified
Journal Article
Closed access
GBGündüzalp Buğrahan Babacan
Gündüzalp Buğrahan Babacan
MTMuge Oner Tamam
Muge Oner Tamam
SSS. Saraçoğlu
S. Saraçoğlu
MTM.N. Acar Tayyar
M.N. Acar Tayyar
MŞM.C. Şahin
M.C. Şahin
EÇEmir Çelik
Emir Çelik

29 April 2023 in İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi
Verified
Journal Article
Open access
PDF file
HYHatice Sümeyye Yavuz
Hatice Sümeyye Yavuz
MTMuge Oner Tamam
Muge Oner Tamam
HOHalim Ozcevik
Halim Ozcevik
AYAhmet Yavuz
Ahmet Yavuz
MMMehmet Mülazimoğlu
Mehmet Mülazimoğlu
Amaç: Günümüzde görüntüleme yöntemlerindeki gelişmeyle birlikte karaciğer hemanjiomlarının saptanması da artmıştır. Genellikle asemptomatik olan karaciğer hemanjiomlarının, karaciğerin diğer primer ve metastatik malign tümörlerinden ayırıcı tanısının konulması gerekmektedir. Özellikle boyutu küçük olan ve ana vasküler yapılara yakın olan lezyonların tanısını koymak önemlidir. Bu tip lezyonlar Tc-99m işaretli eritrosit sintigrafisi ile doğru olarak tanımlanabilir. Bu çalışmanın amacı karaciğer hemanjiomlarının Tc-99m işaretli eritrosit sintigrafisinin SPECT/BT ile değerlendirilmesi ve tanıya olan katkısını araştırmaktır. Yöntem: Hemanjiom ön tanısı ile kliniğimize gönderilen 36 olgudaki 40 lezyon retrospektif olarak değerlendirildi. Modifiye in vivo yöntemle Tc-99m işaretli eritrosit sintigrafisi yapılan 36 hasta SPECT/BT ile görüntülendi. Hastalar 12-24 aylık klinik bulgu ve diğer görüntüleme yöntemleri (USG, BT ve MRG) ile takip edildi. Yapılan takiplerle lezyonların boyut ve morfolojisinde değişiklikler değerlendirilerek tanıları doğrulandı. Bulgular: SPECT/BT ile görüntülemede 36 olgunun 29’unda aktivite artışı saptandı ve bu olguların hepsi gerçek pozitif olarak değerlendirildi. 7 olguda aktivite tutulumu olmadı. 2 olgu kist hidatik, 4 olgu metastaz (1 kolon kanseri, 3 meme kanseri) olarak belirlendi. 1 olgu ise yanlış negatif olarak saptandı. Bu olguda lezyon boyutu 1 cm idi. Tc-99m işaretli eritrosit sintigrafisi-SPECT/BT ile sensitivite:%100; spesifite: %96,7; pozitif prediktif değer: %100; negatif prediktif değer: % 85,7 ve toplam tanı değeri: %97,3 olarak belirlendi. Ayrıca SPECT/BT’de 9 (%25) olguda lezyonlar ana vasküler yapılara yakın yerleşimli idi. Lezyonların 1’i kalbe, 3’ü vena kava inferiora, 5’i ise büyük hepatik damarlara yakın yerleşimli idi. BT sayesinde radyoaktivite akümülasyonunun olduğu odağın doğru anatomik lokalizasyonu yapılarak hastalara hemanjiom tanısı kondu. Sonuç: Tc-99m işaretli eritrosit sintigrafisi SPECT/BT sayesinde karaciğer hemanjiomlarının tespitinde sensitivitesi, spesifitesi ve doğruluğu yüksek olan, fonksiyonel ve anatomik görüntülemenin bir arada yapılmasına sağlayan noninvaziv bir görüntüleme yöntemidir.

24 June 2025 in Revista Española de Medicina Nuclear e Imagen Molecular
Verified
Journal Article
Closed access
MTM.N. Acar Tayyar
M.N. Acar Tayyar
MTMuge Oner Tamam
Muge Oner Tamam
GBGündüzalp Buğrahan Babacan
Gündüzalp Buğrahan Babacan
MŞM. Can Şahin
M. Can Şahin
HOHalim Ozcevik
Halim Ozcevik
KAK. Atakır
K. Atakır